Kashani, Ladan

Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers

Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology

Ovarian function and disordersSirtuins and Resveratrol in Medicine

Cited by 128

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology

Ovarian function and disordersTreatment of Major Depression

Cited by 116

Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial

Mohammadinejad, P., Arya, P., Esfandbod, M., Kaviani, A., Najafi, M., Kashani, L., Zeinoddini, A., Emami, S. A., & Akhondzadeh, S. (2015) · Annals of Pharmacotherapy

Cancer survivorship and careTreatment of Major Depression

Cited by 39

Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial

Moini, A., Kanani, M., Kashani, L., Hosseini, R., & Hosseini, L. (2015) · Endocrine

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 37

Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile

Aghahosseini, M., Aleyaseen, A., Safdarian, L., Moddaress-Hashemi, S., Mofid, B., & Kashani, L. (2010) · Archives of Gynecology and Obstetrics

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 12